Clinical Trials
AZD5305 in Patients with BRCAm localized high-risk prostate cancer
Disease Type: Prostate
A Randomized, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localized High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville